| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,294 | 2,376 | 2,148 | 2,548 | | Cost of Revenue | 1,233 | 275 | 274 |
-
| | | Gross Profit | 61 | 2,101 | 1,874 | 2,548 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,066 | 2,539 | 2,563 | 3,878 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| 15,277 | 1,327 | 41,215 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (27,190) | (15,715) | (2,016) | (42,545) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,544) | 2,622 | (2,742) | (20,483) | | Earnings Before Interest And Taxes | (15,036) | (13,093) | (4,758) | (63,028) | | Interest Expense | 2,406 | 1,427 | 1,649 | 1,665 | | Income Before Tax | (17,442) | (14,520) | (6,407) | (64,693) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (17,442) | (14,520) | (6,407) | (64,693) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (17,442) | (14,520) | (6,407) | (64,693) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($17,442) | ($14,520) | ($6,407) | ($64,693) |
|
0.29% Nasdaq 
0.03 (1.36%) 
Income Statement
